Home › Employers › Atmo Biosciences Inc
Atmo Biosciences Inc: H-1B salaries and sponsorship
Atmo Biosciences Inc filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $120,000.
Does Atmo Biosciences Inc sponsor H-1B visas?
Atmo Biosciences Inc filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Feb 9, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| President | 3 | $122,223 |
| Clinical Research Associate | 1 | $83,950 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 1 | $83,950 |
| FY2024 | 1 | $120,000 |
| FY2025 | 1 | — |
| FY2026 | 1 | $124,446 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| President | $124,446 E-3 · Level I | San Diego, CA | Feb 9, 2026 | Feb 9, 2026 | Certified |
| President | $124,446 part-time · Level I | San Diego, CA | Aug 18, 2025 | Jan 25, 2026 | Certified |
| President | $120,000 E-3 · Level I | San Diego, CA | Jan 11, 2024 | Jan 25, 2024 | Certified |
| Clinical Research Associate | $83,950 E-3 · Level I | San Diego, CA | Feb 27, 2023 | Mar 20, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).